🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Kaiser Franz Josef Hospital
Start Date
1998-04
Trial ID
NCT00003304
Treatments Being Tested
The primary objective of this study is to determine whether zoledronic acid...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-09
Trial ID
NCT00181584
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2000-08
Trial ID
NCT00005955
Treatments Being Tested
The purpose of this study is to determine if Zonisamide is effective in red...
Status
Terminated
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00616343
Treatments Being Tested
The study will evaluate the pharmacokinetics (PK) of AZD6793 when administe...
Status
Completed
Location
Research Site
Start Date
2024-07-23
Trial ID
NCT06494644
Treatments Being Tested
This clinical drug-drug interaction study is being conducted to evaluate th...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00542893
This study is determining the maximum tolerated dose and safety of SU011248...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-07
Trial ID
NCT00712504
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947